Intravenous immunoglobulin induced - Nephropathy: A complication of IVIG therapy

Journal of Nephrology

Volumn 11, Issue 3, 1998, Pages 157-161

  Ahsan, Nasimul ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Acute renal failure; Intravenous immunoglobulin; IVIG; Osmotic nephrosis

Indexed keywords

BIOTRANSFUSION; GAMIMMUNE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ARTICLE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; NEPHROSIS;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFUSIONS, INTRAVENOUS; KIDNEY FAILURE, ACUTE; MIDDLE AGED; RISK FACTORS;

EID: 0031836298     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Berkman SA, Martin LL, Gale RP. Clinical use of intravenous immunoglobulin. Ann Intern Med 1990; 112: 278-92.
2. Berchtold P, Mc Millan R. Therapy of chronic idiopathic thrombocytopenic purpura in adults. Blood 1989; 7: 22309-17.
3. Rodeghiero F, Schiavotto C, Castaman G, Vespagnani M, Ruggeri M, Dini E. A follow-up of 49 adult patients with idiopathic thrombocytopenic purpura treated with high dose immunoglobulin and anti-D immunoglobulin. Heamatologica 1992; 77: 248-52.
4. Sultan Y, Rossi F, Kazatchene MD. Recovery of anti-VIII: C (anti hemophilic factor) auto immune disease is dependent on generation of antiidiotype against anti-VIII:C autoanti-bodies. Proc Nad Acad Sci 1987; 84: 828-32.
5. Torok TL. Parvovirus B19 and human disease. Adv Int Med 1992; 37: 431-55.
6. Kurtzman G, Frickhofen N, Kimball J. Pure red cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Eng J Med 1989; 321: 519-23.
7. Ahsan N, Holman MJ, Gocke CD, Yang HC. Pure red cell aplasia due to parvo virus B19 infection in solid organ transplantation. Clin Transplantation 1997; 11: 265-70.
8. Rostoker G, Desvaux-Belghiti D, Pilatte Y, et al. High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch-Schonlein purpura. Ann Int Med 1994; 120: 476-84.
9. Palla R, Cirami C, Panichi AM, Parrini M, Grazi G. Intravenous immunoglobulin therapy of membranous nephropathy: efficacy and safety. Clin Nephrol 1991; 35: 98-104.
10. Greenbaum BH. Differences in immunoglobulin preparations for intravenous use: a comparison of six products. Am J Pediatr Hematol Oncol 1990; 12: 490-3.
11. Ahsan N, Palmer BF, Wheeler D, Greenlee RG, Toto RD. Intravenous immunoglobulin-induced osmotic nephrosis. Arch Intern Med 1994; 154: 1985-7.
12. Rault R, Piraino B, Johnston JR, Oral A. Pulmonary and renal toxicity of intravenous immunoglobulin. Clinical Nephrol 1991; 36: 83-6.
13. Tan E, Hajinazarian M, Bay W, Neff J, Mendell JR. Acute renal failure resulting from intravenous immunoglobulin therapy. Arch Neurol 1993; 50: 137-39.
14. Hansen-Schmidt S, Silomon J, Keller F. Osmotic nephrosis due to high-dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis. Am J Kid Dis 1996; 28: 451-3.
15. Donatini B. Transient renal dysfunction in diabetic patient after IVIG therapy. J Intern Med 1992; 232: 376.
16. Philips AO. Renal failure after intravenous immunoglobulin.Clin Nephrol 1992; 37: 217.
17. Kobosko J, Nicol P. Renal toxiciry of intravenous immunoglobulin. Clin Nephrol 1992; 37: 216-7.
18. Cantu TG, Hoehn-Saric EW, Burgess KM, Racusen L, Scheel PJ. Acute renal failure associated with immunoglobulin therapy. Am J Kid Dis 1994; 25: 228-34.
19. Ellie E, Combe C, Ferrer X. High-dose intravenous immunoglobulin and acute renal failure. N Engl J Med 1992; 327: 1032-3.
20. Barton JC, Herrera GA, Galla JH, Bertoli LF, Work J, Koopman WJ. Acute cryoglobulinemic renal failure after intravenous infusion of gamma globulin. Am J Medicine 1987; 82: 624-9.
21. Ahsan N, Weigand LA, Abendroth CS, Manning EC. Acute renal failure following immunoglobulin therapy. Am J Nephrol 1996; 16: 532-6.
22. Schifferli J, Favre H, Nydegger U, Leski M, Imbach P, Davies K. High-dose intravenous IgG treatment and renal function. Lancet 1991; 337: 457-8.
23. Coevetta A, Della Bitta R, Gabrielli A, Spaaeth PJ, Daniel G. Use of high-dose intravenous immunoglobulin in systemic lupus erythematosus: Report of three cases. Clin Exp Rheumatol 1989; 7: 295-99.
24. Friedman KD, Saddler MC, Tarnower AC, Yang G, Harford AM. Transient renal failure in a patient with idiopathic throbocytopenic purpura after treatment with concomitant proteinA immunosorption and intravenous globulin (Abstract). Blood 1992 (suppl 1); 80: 483a.
25. Pastiempo AMG, Kroser JA, Rudnick M, Hoffman B. Acute renal failure of intravenous immunoglobulin. J Rheumatol 1994; 21: 347-9.
26. Stewart RRC, Winney RJ, Cash JD. Renal toxicity of intravenous immunoglobulin. Vox Sang 1993; 65: 244.
27. Veber B, Mohammedi I, Gachot B, Bedos JP, Wolff M. High-dose intravenous IgG treatment and acute renal failure. Int Care Med 1995; 21: 288-9.
28. Ruggeri M, Castman G, Nardi GD, Roedeghiero F. Acute renal failure after high-dose intravenous immune globulin in a patient with idiopathic thrombocytopenic purpura. Haematologica 1993; 78: 338-9.
29. Rostoker G, Philippon C, Belghiti D, et al. Intravenous IgG for glomerulonephritis and renal function. Lancet 1991; 338: 54-5.
30. Cayco AV, Perazella MA, Hayslett JP. Renal insufficiency after intravenous globulin therapy: a report of two cases and an analysis of the literature. J Am Soc Nephrol 1997; 8: 1788-94.
31. Poullin P, Moulen B, Ollier J, Benarcha M, Olmer M, Gabriel B. Hyperoncotic renal failure after intravenous immunoglobulin therapy. Presse Med 1995; 24: 441-4.
32. Arunabh S, Kuman G, Avila V. Acute renal failure induced by intravenous immune globulin. Am Fam Physician 1996; 53: 862-3.
33. Winward DB, Brophy MT. Acute renal failure after administration of intravenous immunoglobulin: review of the literature and case report. Pharmacotherapy 1995; 15: 765-72.
34. Physicians Desk Reference. Edition 49, 1995. Medical Economics, Motavale, NJ.
35. Cutler HH. Effects of sucrose on the kidney: Proc Staff Meet Mayo Clin 1939; 14: 318-20.
36. Anderson WD. Sucrose nephrosis and other types of renal tubular injuries. South MJ 1941; 34: 257-63.
37. Rigdon RH, Cardwell ES. Renal lesions following the intravenous injection of hypertonic solution of sucrose; a clinical and experimental study. Arch Int Med 1942; 69: 670-90.
38. Schwartz SL, Johnson CB. Pinocytosis as the cause of sucrose nephrosis.Nephron 1971; 8: 246-54.
39. Dorman HR, Sondheimer JH, Cadnapaphornchai P. Mannitol-induced acute renal failure. Medicine 1990; 69: 153-9.
40. Juncos LA, Garcia NH, Amin J, Garvin JL. Immunoglobulin therapy directly impairs the function of proximal staight tubules and afferent arterioles (Abstract). J Am Soc Nephrol 1995; 6: 467.